Skip to main content

Table 3 Studies including lncRNA BDNF-AS and MT1JP in cancers

From: Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis

First author

Year

Diseases

Sample size

Assay

Expression

Potential targets

LncRNA BDNF-AS

 Huaying Zhao [26]

2018

Oesophageal cancer

45 pairs of surgical primary EC tissues

qPCR

Downregulated

miR‐214

 Huimin Zhang [27]

2018

Cervical cancer

125 pairs of cancer cervix tissues

qPCR

Downregulated

BDNF

 Hui Zhi [28]

2019

Colorectal cancer (CRC)

20 pairs of CRC tissues

qPCR

Downregulated

GSK-3β

 Wensheng Li [29]

2018

Prostate cancer (CaP)

141 pairs of surgical CaP tissues

qPCR

Downregulated

NA

 Qiang Huang [30]

2018

Osteosarcoma (OS)

114 OS samples

35 paired non-cancerous samples

qPCR

Downregulated

cleaved caspase-3

 Farbod Esfandi [30]

2019

Gastric cancer

30 pairs of cancer specimens

qPCR

Downregulated

NA

LncRNA MT1JP

 Ying Xu [31]

2018

Gastric cancer

99 pairs of GC tissues and neighboring noncancerous tissues

qPCR

Downregulated

MT1JP/MiR-214-3p/RUNX3

 Gang Zhang [32]

2018

Gastric cancer

5 pairs of normal and GC tissues + 75 paired tissues

qPCR

Downregulated

MT1JP/MiR-92a-3p/FBXW7

 Donglei Zhu [33]

2019

Breast cancer

56 paired samples of breast cancer tissue and adjacent normal breast tissues

qPCR

Downregulated

miR-24-3p

 Haifeng Yu [34]

2019

Bladder tumor

35 paired samples of bladder cancer samples and adjacent no‐tumor samples

qPCR

Downregulated

miR-214-3p

 Jiyong Ma [35]

2019

Lung cancer

30 non-small cell lung cancer (NSCLC) and adjacent normal tissues

qPCR

Downregulated

miRNA-423-3p/Bim